Exponent Inc

Exponent Inc(EXPO)股票分析

$72.250

+0.405 (+0.56%)收盘时

Loading chart…
最高
72.900
开盘
71.510
成交量加权均价
72.09
成交量
603.95K
市值
4.85B
最低
71.120
成交额
43.54M
企业价值/息税折旧摊销前利润(TTM)
25.37

Exponent, Inc., together with its subsidiaries, is a science and engineering consulting firm that provides solutions to complex problems. The Company’s segments include Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and their impact on both human health and the environment. It serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation and other sectors of the economy. The Company’s service offerings are provided on a project-by-project basis.

AI 分析 of Exponent Inc (EXPO)

买入

Exponent Inc is a good buy right now due to its strong financial performance, with a current price of $71.85 and an impressive gross margin of 100%. The company reported a Q2 2026 EPS of $0.60, beating expectations by $0.05, and has raised its revenue guidance for fiscal 2026, anticipating a growth of 9% to 10%. However, the main risk is the forward P/E ratio of 31.55, indicating that the stock may be overvalued if growth does not meet expectations.

分析师评级(4)

上行空间 +18.34%
持有
1 买入
3 持有
0 卖出
当前: 72.25
最低
81.00
平均
85.50
最高
90.00

UBS

2026-07-31

目标价

$72

中性

JPMorgan

2026-07-31

目标价

$90

增持

JPMorgan

2026-05-15

目标价

$80

增持

UBS

2026-05-01

目标价

$75

中性

JPMorgan

2026-03-26

目标价

$95

增持

估值指标

Exponent Inc(EXPO)当前预期市盈率为 31.55,5 年平均预期市盈率为 42.60。

预期市盈率

低估
5 年均值 P/E
42.60
当前P/E
31.55
高估
51.55
低估
33.66

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
29.70
当前EV/EBITDA
25.37
高估
36.65
低估
22.76

预期市销率

低估
5 年均值 P/S
8.49
当前P/S
5.15
高估
10.72
低估
6.26

Alphio AI 对 EXPO 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%EXPO

$68.96

情景价格

基

基准

基准 · 50%EXPO

$67.10

情景价格

悲

悲观

悲观 · 25%EXPO

$58.23

情景价格

持有 EXPO 的大户

R

Roffman Milller Associates Inc

+ 持有EXPO

+2.71%

3个月收益率

R

Royce & Associates, LP

+ 持有EXPO

-13.09%

3个月收益率

事件时间线

2026-07-30 (ET)

17:00:00

Exponent Increases Share Repurchase Authorization by $50M

16:30:00

Exponent Sees Q3 Adjusted EBITDA at 28%-28.5% of Revenue

16:30:00

Exponent Reports Q2 Revenue of $148.86M

16:30:00

Company Raises FY26 Adjusted EBITDA Outlook to 27.8%-28.1%

2026-04-30 (ET)

17:10:00

Exponent's Board Increases Share Repurchase Authority by $50M

资讯

EXPO 常见问题 —— 由 Alphio AI 解答

Exponent, Inc., together with its subsidiaries, is a science and engineering consulting firm that provides solutions to complex problems. The Company’s segments include Engineering and Other Scientific and Environmental and Health. The Engineering and Other Scientific segment is a broad service group providing technical consulting in different practices, primarily in engineering. The Environmental and Health segment provides services in the area of environmental, epidemiology and health risk analysis. This segment provides a wide range of consulting services relating to environmental hazards and risks and their impact on both human health and the environment. It serves clients in chemicals, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation and other sectors of the economy. The Company’s service offerings are provided on a project-by-project basis. It operates in the Industrials sector (SERVICES-MANAGEMENT CONSULTING SERVICES industry).

Exponent Inc is a good buy right now due to its strong financial performance, with a current price of $71.85 and an impressive gross margin of 100%. The company reported a Q2 2026 EPS of $0.60, beating expectations by $0.05, and has raised its revenue guidance for fiscal 2026, anticipating a growth of 9% to 10%. However, the main risk is the forward P/E ratio of 31.55, indicating that the stock may be overvalued if growth does not meet expectations.

4 analysts cover EXPO: 1 rate it Buy, 3 Hold and 0 Sell. The average price target is 85.50.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易